PACS vs ENSG vs NHC

For growth investors, PACS Group, Inc.

(PACS) is the stronger pick with 29. 3% revenue growth year-over-year, versus 13. 2% for National HealthCare Corporation (NHC). National HealthCare Corporation (NHC) offers the better valuation at 22. 3x trailing P/E (21. 5x forward), making it the more compelling value choice. Analysts rate PACS Group, Inc. (PACS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National HealthCare Corporation (NHC) is the cheapest at 22.

3x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, PACS Group, Inc. is actually cheaper at 16. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: National HealthCare Corporation wins at 0. 93x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, National HealthCare Corporation (NHC) delivered a total return of +162.

1%, compared to +46. 2% for PACS Group, Inc. (PACS). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus PACS's +46. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus PACS Group, Inc. 's 0. 64β — meaning PACS is approximately 52% more volatile than ENSG relative to the S&P 500. On balance sheet safety, National HealthCare Corporation (NHC) carries a lower debt/equity ratio of 8% versus 3% for PACS Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), PACS Group, Inc.

(PACS) is pulling ahead at 29. 3% versus 13. 2% for National HealthCare Corporation (NHC). On earnings-per-share growth, the picture is similar: PACS Group, Inc. grew EPS 221. 1% year-over-year, compared to 14. 1% for The Ensign Group, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National HealthCare Corporation (NHC) is the more profitable company, earning 8.

2% net margin versus 3. 6% for PACS Group, Inc. — meaning it keeps 8. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHC leads at 8. 7% versus 5. 9% for PACS. At the gross margin level — before operating expenses — NHC leads at 37. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, National HealthCare Corporation (NHC) is the more undervalued stock at a PEG of 0. 93x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, PACS Group, Inc. (PACS) trades at 16. 2x forward P/E versus 23. 2x for The Ensign Group, Inc. — 6. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PACS: 32. 9% to $44. 67.

In this comparison, NHC (1.

4% yield), ENSG (0. 1% yield) pay a dividend. PACS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, PACS: +46. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PACS (Financial Services) and ENSG (Healthcare) and NHC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PACS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; NHC is a small-cap quality compounder stock. NHC pays a dividend while PACS, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.